Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT05080673 · NRG Oncology

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

(FORTE)

What this study is about

This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomly assigned to surveillance colonoscopy at 10 years compared to participants randomly assigned to surveillance colonoscopy at 5 and 10 years.

View original scientific description

This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years.

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • The participant must have signed and dated an IRB-approved consent form that conforms to federal and institutional guidelines.
  • Participants greater than or equal to 45 and less than 70 years of age at the time of colonoscopy.
  • Participants with a first-time diagnosis of 1-2 non-advanced tubular adenomas (less than 10 mm without tubulovillous or villous changes or high grade or severe dysplasia) from the qualifying colonoscopy within 4 years prior to randomization.
  • Sessile serrated polyps/adenomas, as long as they do not meet the criteria for advanced adenomas, will be considered as non-advanced adenomas.
  • Qualifying colonoscopy must be a complete colonoscopy with visualization of the cecum and with adequate cleansing within 4 years prior to randomization.
  • Complete excision of all observed polyps in qualifying colonoscopy
  • Participants must be able to read or understand English or Spanish.

Exclusion criteria

  • • Prior history of colorectal cancer or colorectal adenomas including sessile serrated polyps/adenomas excluding those found on the qualifying colonoscopy.
  • Prior history of a hyperplastic polyp measuring greater than or equal to 1 cm in size.
  • Traditional serrated adenomas found on the qualifying colonoscopy.
  • Hyperplastic polyp measuring greater than or equal to 1 cm in size found on the qualifying colonoscopy.
  • Previous malignancies unless the patient has been disease-free for 5 or more years prior to randomization and is deemed by the physician to be at low risk for recurrence. Patients with the following cancers are eligible if diagnosed and treated within the past 5 years: all in situ cancers and basal cell and squamous cell carcinoma of the skin.
  • Colonoscopy performed after the qualifying colonoscopy but prior to randomization.
  • Incomplete qualifying colonoscopy (e.g., cecum not visualized).
  • Incomplete endoscopic excision of adenomatous polyps based on colonoscopist impression at qualifying colonoscopy. (Excision of all hyperplastic rectosigmoid polyps is not required.)
  • Sub-total colectomy or total proctocolectomy. (Segmental resections are allowed.)
  • Family history of CRC diagnosed at less than or equal to 60 years of age in a first degree relative (mother, father, child, sibling) or in two first degree relatives with CRC at any age.
  • Participants with a clinical diagnosis of a significant heritable risk for colorectal cancer (Familial Adenomatous Polyposis, Hereditary Nonpolyposis Colorectal Cancer \[Lynch Syndrome\]).
  • Participants tested positive for a Familial Adenomatous Polyposis, Hereditary Nonpolyposis Colorectal Cancer \[Lynch Syndrome\] genetic mutation that increases risk of colorectal cancer.
  • Inflammatory bowel disease (e.g., Crohn's Disease, ulcerative colitis).
  • Life expectancy less than 10 years due to comorbid conditions in the opinion of the investigator.
  • Other comorbid conditions that would prevent the participant from having colonoscopies or would prevent required follow-up.

Where

  • Fairbanks, Alaska
  • Goodyear, Arizona
  • Kingman, Arizona
  • Phoenix, Arizona
  • Tucson, Arizona
  • Fort Smith, Arkansas
  • Hot Springs, Arkansas
  • Little Rock, Arkansas
  • Anaheim, California
  • Arroyo Grande, California
  • Baldwin Park, California
  • Bellflower, California

And 311 more locations — see the full list below.

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Jul 2, 2026 · Source of record for eligibility and locations

📊
1 of 9500 participants interested
0% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Fairbanks

Alaska

Location available
RECRUITING

Goodyear

Arizona

Location available
RECRUITING

Kingman

Arizona

Location available
RECRUITING

Phoenix

Arizona

Location available
RECRUITING

Tucson

Arizona

Location available
RECRUITING

Fort Smith

Arkansas

Location available
SUSPENDED

Hot Springs

Arkansas

Location available
RECRUITING

Little Rock

Arkansas

Location available
RECRUITING

Anaheim

California

Location available

And 462 more locations available.

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Alzheimers Disease Trials by City

Browse all alzheimers disease clinical trials in these cities — not just this study.

Looking for Adenocarcinoma of the Colon Treatment in Fairbanks?

Join others in Alaska exploring innovative treatment options through clinical research

Adenocarcinoma of the Colon Treatment Options in Fairbanks, Alaska

If you're searching for Adenocarcinoma of the Colon treatment in Fairbanks, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Fairbanks, Goodyear, Kingman and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Adenocarcinoma of the Colon. All study-related care is provided at no cost to participants.

Local Sites
3 locations in Alaska
Now Enrolling
Up to 9500 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Adenocarcinoma of the Colon?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Adenocarcinoma of the Colon

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Adenocarcinoma of the Colon Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT05080673. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.